Financials
Income statement
Fiscal date | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 |
---|---|---|---|---|
Total reported revenue | — | 146.3B | 126.1B | 130.3B |
Cost of revenue | — | 84.7B | 71.2B | 74.5B |
Gross profit | — | 61.6B | 54.9B | 55.9B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | — | — | — | — |
Operating income | — | 22.0B | 18.2B | 19.3B |
Non operating interest income | ||||
Income | — | 320M | 335M | 360M |
Expense | — | 72M | 81M | 71M |
Other income expense | — | — | — | — |
Pretax income | — | 24.0B | 17.0B | 20.2B |
Tax provision | — | 6.0B | 4.5B | 4.8B |
Net income | — | 18.0B | 12.5B | 15.4B |
Basic EPS | 33.9 | — | — | — |
Diluted EPS | 33.9 | — | — | — |
Basic average shares | 294.7M | — | — | — |
Diluted average shares | 294.7M | — | — | — |
EBITDA | — | 23.9B | 17.1B | 20.2B |
Net income from continuing op. | — | — | — | — |
Minority interests | — | 0 | 0 | 0 |
Preferred stock dividends | — | 0 | 0 | 0 |